Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt-Reference-Cited by-同舟云学术

Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt

Published:2013-05-09 Issue:5 Volume:8 Page:e63605
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tartof Sara,Cohn Amanda,Tarbangdo Félix,Djingarey Mamoudou H.,Messonnier Nancy,Clark Thomas A.,Kambou Jean Ludovic,Novak Ryan,Diomandé Fabien V. K.,Medah Isaïe,Jackson Michael L.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa;AM Molesworth;Trans R Soc Trop Med Hyg,2002

2. [Cerebrospinal Meningitis in Africa];L Lapeyssonnie;Bull World Health Organ,1963

3. World Health Organization (1998) Control of epidemic meningococcal disease: WHO practical guidelines (WHO/EMC/BAC/98.3). 2nd ed. Geneva: World Health Organization.

4. Meningococcal disease and season in sub-Saharan Africa;BM Greenwood;Lancet,1985

5. Infectious disease. An ill wind, bringing meningitis;L Roberts;Science,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model;Journal of Benefit-Cost Analysis;2023-09-14

2. Modeling the vaccination control of bacterial meningitis transmission dynamics: a case study;Mathematical Modelling and Control;2023

3. COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery;Vaccine;2022-07

4. COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery;2022-01-07

5. ‘Learn from the lessons and don’t forget them’: identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns;BMJ Global Health;2021-09